Milrinone at home with beta-blockers and GDMT may be better than dobutamine. Hypothesis generating data. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine - Journal of Cardiac Failure onlinejcf.com/article/S1071-…

Keck Medicine of USC Heart Transplant Program proudly has 5 bars, or a 98.2%, 1-year heart transplant survival rate! Congratulations to the entire team for providing our patients with this first-class service. It takes a village!

We are immensely proud of this achievement and the multidisciplinary team behind this! Dr Raymond C Lee MD Kori Ajay Vaidya Aaron Wolfson Rachel Cartus @sylveeuh1 jonathan praeger Serge S. Kobsa, MD, PhD J. Alex Weston Yoni Nattiv @KeckMedUSC

Congratulations, Will!!

We’re honored to have USCHeartFailure featured by Rod Hanners & @KeckMedUSC. We have an amazing team providing exceptional care to the entire #LA community! buff.ly/3EJFoGN Dr Raymond C Lee MD Kori Ajay Vaidya Aaron Wolfson Serge S. Kobsa, MD, PhD jonathan praeger Yoni Nattiv

This one hits too close to home. Thank you to my lovely wife Adriana Diaz for highlighting the burden of CV disease in Black ppl + solutions to this disparity: only 3% of cardiologists are black! Jamarcus Brider, DO Clyde Yancy, MD, MSc Quentin Youmans, MD, MSc, FACC Shirlene Obuobi MD Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA American Heart Association

Congratulations to the Dr. Jon Kobashigawa, director of Advanced Heart Disease and the Heart Transplant Program in the Smidt Heart Institute at Cedars-Sinai, on being selected to receive the 2023 Lifetime Achievement Award from the The ISHLT at #ISHLT2023! 🎉 ceda.rs/3K9OPTb

Smoking kills- through heart attacks, strokes, emphysema, and cancer. So we encourage patients to quit cigarettes. Handgun ownership dramatically increases the risk of dying by suicide. So why don’t we encourage patients to quit handguns?

#HFinductiontherapy is as important as cancer induction chemotherapy- HF is as deadly as cancer is and HF GDMT improve outcomes. Initiate quadruple HF therapies as induction therapy and then consider add-on therapies as consolidation therapy in HFrEF. jacc.org/doi/10.1016/j.…

Gotta love this team USC Cardiac Antonio Polanco, MD J. Alex Weston Serge S. Kobsa, MD, PhD Tom C. Nguyen, MD

⁦ABIM Foundation⁩ please reply here so we all understand what these MOC fees get us. Paying the >$3,000 to pass the general and interventional cardiology recert exams isn’t enough for you. Please explain why. No answer assumes greed. We will all wait…

Congratulations, Jainy. Your mentees are lucky to have you!

Huge congratulations!!

I’m delighted to join as faculty for this outstanding fellowship program PITCH has great structured mentorship + formal training in UChicago Public Health Sciences- get the necessary empirical skills to take on hard, important questions

Following the 2018 UNOS policy change, the rates of #HTx for higher acuity patients increased while the risk of rejection and treated rejection decreased over time without impacting the risk of hospitalization for rejection and infection. Ajay Vaidya 🔗: jhltonline.org/article/S1053-…

Excited to see our recommendations for best statistical practice for analyzing waitlist urgency in JHLT - a key question when evaluating organ transplantation policies Great to work with Grace R. Lyden, PhD Daniel Johnson Jessie Golbus Jon J. Snyder, PhD authors.elsevier.com/c/1iEo23lUpLZv…

Our new case report in asaiojournal of a young woman with prior NICM and durable LVAD, with subsequent recovery and LVAD explantation, who had a successful pregnancy. Aaron Wolfson

Cutting edge and an excellent read! I highly recommend!

Excited to announce that we are looking to grow our HF family by adding a full-time HF/HTx/MCS cardiologist here at USC! It will involve a leadership role in growing HF care at our partner hospitals as well as contributing to our AHF/MCS/transplant services. DM me if interested!